Condition Lookup
Sub-Category:
Developmental Disorders
Number of Conditions: 4
Autism spectrum disorder (ASD)
Specialty: Pediatrics
Category: Growth and Development Disorders
Sub-category: Developmental Disorders
Symptoms:
difficulty with social interaction; delayed language development; repetitive behaviors; restricted interests; sensory sensitivities
Root Cause:
Neurological and developmental differences affecting communication, behavior, and social interaction. The exact cause is not known, but it involves genetic and environmental factors.
How it's Diagnosed: videos
Clinical evaluation by developmental specialists, developmental screenings, and the use of diagnostic tools such as the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview-Revised (ADI-R).
Treatment:
Behavioral therapy (e.g., Applied Behavior Analysis), speech and language therapy, occupational therapy, and educational interventions tailored to the child's needs.
Medications:
Medications may include selective serotonin reuptake inhibitors (SSRIs) for anxiety, antipsychotics like risperidone and aripiprazole for irritability, and stimulants for associated ADHD symptoms.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 1 in 36 children in the United States, with variations worldwide.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history of ASD, genetic mutations, advanced parental age, low birth weight, and exposure to certain environmental factors during pregnancy.
Prognosis:
The expected outcome or course of the condition over time.
Outcomes vary widely; with early intervention and tailored therapies, many individuals develop improved communication and social skills.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Difficulties with independent living, increased risk of anxiety, depression, epilepsy, and intellectual disability.
Fragile X syndrome
Specialty: Genetics
Category: Neurological and Neurodegenerative Disorders
Sub-category: Developmental Disorders
Symptoms:
intellectual disability; behavioral challenges; delayed speech and language development; anxiety; hyperactivity; sensory sensitivities; characteristic physical features such as long face, prominent ears, and flat feet
Root Cause:
Mutation in the FMR1 gene leading to a deficiency of the Fragile X Mental Retardation Protein (FMRP), which is critical for normal neural development.
How it's Diagnosed: videos
Diagnosed via genetic testing for FMR1 gene mutations.
Treatment:
Treatment includes supportive therapies, with medications like stimulants (e.g., methylphenidate) for ADHD symptoms and SSRIs for anxiety.
Medications:
Medications may include stimulants (e.g., methylphenidate for ADHD symptoms), selective serotonin reuptake inhibitors (SSRIs) for anxiety, and antipsychotics (e.g., risperidone ) for behavioral issues. These are classified as psychoactive medications.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 1 in 4,000 males and 1 in 8,000 females globally.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history of Fragile X syndrome or other genetic disorders.
Prognosis:
The expected outcome or course of the condition over time.
While there is no cure, early intervention and ongoing support can improve quality of life. Intellectual disability typically persists throughout life.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Increased risk of seizures, autism spectrum disorder, and social isolation.
Rett syndrome
Specialty: Genetics
Category: Neurological and Neurodegenerative Disorders
Sub-category: Developmental Disorders
Symptoms:
loss of purposeful hand skills; stereotypic hand movements; loss of speech; intellectual disability; gait abnormalities; seizures; breathing irregularities
Root Cause:
Mutations in the MECP2 gene on the X chromosome disrupt normal brain development and function.
How it's Diagnosed: videos
Diagnosed with genetic testing for MECP2 mutations.
Treatment:
Treated with supportive care, including physical and speech therapy, and medications like antiepileptics for seizures and muscle relaxants for spasticity.
Medications:
Anticonvulsants for seizures (e.g., valproic acid, levetiracetam ), beta-blockers for autonomic dysfunction, and anxiolytics for anxiety. These are classified as anticonvulsants, beta-blockers, and anxiolytics.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 1 in 10,000 to 15,000 live female births worldwide; rare in males.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Sporadic mutation; rarely inherited.
Prognosis:
The expected outcome or course of the condition over time.
Progressive disorder; life expectancy can be reduced due to complications such as respiratory issues, though some live into middle age with proper care.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Severe mobility impairment, scoliosis, respiratory infections, and gastrointestinal problems.
Angelman syndrome
Specialty: Genetics
Category: Neurological and Neurodegenerative Disorders
Sub-category: Developmental Disorders
Symptoms:
severe intellectual disability; delayed development; speech impairment; frequent laughter or smiling; happy demeanor; ataxia; seizures; sleep disturbances
Root Cause:
Loss of function in the UBE3A gene due to deletion, mutation, or other genetic changes on chromosome 15 (maternal copy).
How it's Diagnosed: videos
Diagnosed via genetic testing for UBE3A gene abnormalities.
Treatment:
Treatment is supportive, with antiepileptics for seizures, physical therapy, and behavioral interventions.
Medications:
Anticonvulsants for seizures (e.g., clonazepam , topiramate ), and melatonin for sleep disturbances. These are classified as anticonvulsants and sleep aids.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 1 in 12,000 to 20,000 people globally.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Sporadic mutation or inheritance of paternal uniparental disomy (rare).
Prognosis:
The expected outcome or course of the condition over time.
No cure, but individuals can live into adulthood with proper care; intellectual disability and other symptoms are lifelong.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Seizures, scoliosis, feeding difficulties, and limited ability to live independently.